Acute kidney injury (AKI) is a deterioration of renal function over hours to days resulting in failure to excrete waste and maintain homeostasis. [1] There are over 35 AKI definitions showing its complexity. [2] It can be classified as oliguric/non-oliguric or prerenal, renal, postrenal. [3] Prerenal and acute tubular necrosis account for most hospital AKI cases. [4] Management involves diagnosis through tests and imaging, and treatment focusing on fluid balance, electrolytes, and potentially renal replacement therapy. [5] The prognosis remains poor especially in critically ill patients, as currently the condition can only be supported but not cured. [6
This document provides an overview of acute kidney injury (AKI). It defines AKI and notes its worldwide epidemiology. The main causes of AKI are discussed as pre-renal, renal, and post-renal. The pathophysiology of each type is explained. Clinical presentation depends on the cause but may include elevated creatinine and reduced urine output. Staging of AKI is outlined using KDIGO criteria. Investigations and management aim to identify and treat the underlying cause while maintaining fluid and electrolyte balance. Complications include fluid overload and metabolic disturbances. Prognosis depends on severity and comorbidities.
Acute tubular necrosis is damage and necrosis of the renal tubule epithelial cells, usually caused by ischemia or nephrotoxic drugs. It presents with muddy brown casts or renal tubular cells in the urine and increased creatinine and BUN. Management involves treating the underlying cause, stopping nephrotoxic drugs, managing fluid balance and electrolyte abnormalities, and considering dialysis for refractory complications like fluid overload or uremia. Prognosis depends on the severity of the initial injury and development of complications.
This document summarizes the pathophysiology of acute kidney injury (AKI). It describes AKI as an abrupt reduction in kidney function that can be diagnosed through changes in creatinine, BUN, and urine output levels. The pathophysiology of AKI is categorized into pre-renal, intrinsic, and post-renal forms. Pre-renal AKI is due to reduced blood flow to the kidneys, intrinsic AKI involves direct kidney damage, and post-renal AKI is caused by urinary outflow obstruction. The goals of treatment are to minimize injury, reduce complications, and restore kidney function through supportive care, fluid management, and renal replacement therapies like hemodialysis in severe cases
The document discusses acute kidney injury (AKI), including its definition, classification, causes, diagnostic evaluation and management. AKI can be prerenal, intrinsic renal or postrenal. Prerenal AKI is due to reduced renal blood flow and reversible. Intrinsic renal AKI involves direct kidney damage from factors like ischemia or toxins. Postrenal AKI is due to urinary tract obstruction. Evaluation includes urine and blood tests. Management focuses on treating the underlying cause, maintaining fluid/electrolyte balance and preventing complications through supportive care and possibly dialysis.
AKI is common in ICU patients and is associated with high mortality. It is defined based on changes in serum creatinine and urine output. The RIFLE criteria is commonly used for classification. Causes include prerenal, intrinsic renal and post renal factors. Treatment involves identifying and treating the underlying cause, fluid resuscitation, and renal replacement therapy like intermittent hemodialysis or continuous renal replacement therapy as needed. Prevention strategies focus on ensuring adequate perfusion and minimizing nephrotoxins. Outcomes remain poor despite treatment.
The document discusses acute kidney injury (AKI). It defines AKI and outlines its causes including pre-renal, intrinsic renal, and post-renal etiologies. Diagnosis involves evaluating history, examination for volume status, and investigations such as blood tests, urinalysis, and imaging. Urinalysis can provide clues to the etiology such as presence of red blood cells or casts. Ultrasound is useful for assessing kidney size and detecting obstruction. Managing the underlying cause and treating complications are important in AKI.
This document provides an overview of acute kidney injury (AKI) including renal anatomy and physiology, epidemiology, definitions, diagnosis, biomarkers, and treatment. It discusses the kidney's role in fluid, electrolyte and waste regulation. AKI is common, affecting 5-30% of hospitalized or ICU patients. New definitions classify AKI severity into Risk, Injury and Failure stages based on creatinine and urine output. Causes include pre-renal, intrinsic renal and post-renal factors. Treatment focuses on fluid management, electrolyte control, nutrition and preventing complications through dialysis if needed. Biomarkers show promise in early AKI detection but management primarily relies on supportive care as no targeted therapies exist
Acute kidney injury (AKI) is a deterioration of renal function over hours to days resulting in failure to excrete waste and maintain homeostasis. [1] There are over 35 AKI definitions showing its complexity. [2] It can be classified as oliguric/non-oliguric or prerenal, renal, postrenal. [3] Prerenal and acute tubular necrosis account for most hospital AKI cases. [4] Management involves diagnosis through tests and imaging, and treatment focusing on fluid balance, electrolytes, and potentially renal replacement therapy. [5] The prognosis remains poor especially in critically ill patients, as currently the condition can only be supported but not cured. [6
This document provides an overview of acute kidney injury (AKI). It defines AKI and notes its worldwide epidemiology. The main causes of AKI are discussed as pre-renal, renal, and post-renal. The pathophysiology of each type is explained. Clinical presentation depends on the cause but may include elevated creatinine and reduced urine output. Staging of AKI is outlined using KDIGO criteria. Investigations and management aim to identify and treat the underlying cause while maintaining fluid and electrolyte balance. Complications include fluid overload and metabolic disturbances. Prognosis depends on severity and comorbidities.
Acute tubular necrosis is damage and necrosis of the renal tubule epithelial cells, usually caused by ischemia or nephrotoxic drugs. It presents with muddy brown casts or renal tubular cells in the urine and increased creatinine and BUN. Management involves treating the underlying cause, stopping nephrotoxic drugs, managing fluid balance and electrolyte abnormalities, and considering dialysis for refractory complications like fluid overload or uremia. Prognosis depends on the severity of the initial injury and development of complications.
This document summarizes the pathophysiology of acute kidney injury (AKI). It describes AKI as an abrupt reduction in kidney function that can be diagnosed through changes in creatinine, BUN, and urine output levels. The pathophysiology of AKI is categorized into pre-renal, intrinsic, and post-renal forms. Pre-renal AKI is due to reduced blood flow to the kidneys, intrinsic AKI involves direct kidney damage, and post-renal AKI is caused by urinary outflow obstruction. The goals of treatment are to minimize injury, reduce complications, and restore kidney function through supportive care, fluid management, and renal replacement therapies like hemodialysis in severe cases
The document discusses acute kidney injury (AKI), including its definition, classification, causes, diagnostic evaluation and management. AKI can be prerenal, intrinsic renal or postrenal. Prerenal AKI is due to reduced renal blood flow and reversible. Intrinsic renal AKI involves direct kidney damage from factors like ischemia or toxins. Postrenal AKI is due to urinary tract obstruction. Evaluation includes urine and blood tests. Management focuses on treating the underlying cause, maintaining fluid/electrolyte balance and preventing complications through supportive care and possibly dialysis.
AKI is common in ICU patients and is associated with high mortality. It is defined based on changes in serum creatinine and urine output. The RIFLE criteria is commonly used for classification. Causes include prerenal, intrinsic renal and post renal factors. Treatment involves identifying and treating the underlying cause, fluid resuscitation, and renal replacement therapy like intermittent hemodialysis or continuous renal replacement therapy as needed. Prevention strategies focus on ensuring adequate perfusion and minimizing nephrotoxins. Outcomes remain poor despite treatment.
The document discusses acute kidney injury (AKI). It defines AKI and outlines its causes including pre-renal, intrinsic renal, and post-renal etiologies. Diagnosis involves evaluating history, examination for volume status, and investigations such as blood tests, urinalysis, and imaging. Urinalysis can provide clues to the etiology such as presence of red blood cells or casts. Ultrasound is useful for assessing kidney size and detecting obstruction. Managing the underlying cause and treating complications are important in AKI.
This document provides an overview of acute kidney injury (AKI) including renal anatomy and physiology, epidemiology, definitions, diagnosis, biomarkers, and treatment. It discusses the kidney's role in fluid, electrolyte and waste regulation. AKI is common, affecting 5-30% of hospitalized or ICU patients. New definitions classify AKI severity into Risk, Injury and Failure stages based on creatinine and urine output. Causes include pre-renal, intrinsic renal and post-renal factors. Treatment focuses on fluid management, electrolyte control, nutrition and preventing complications through dialysis if needed. Biomarkers show promise in early AKI detection but management primarily relies on supportive care as no targeted therapies exist
This document provides an overview of acute liver failure (ALF), including its definition, classification, etiology, clinical manifestations, diagnosis, treatment, complications, prognosis, and liver support devices. ALF is defined as evidence of coagulation abnormalities and mental alterations in a patient without preexisting cirrhosis within 26 weeks of illness onset. Common etiologies in India include hepatitis E, drug-induced liver injury, and acetaminophen toxicity. Presentation may include jaundice, coagulopathy, and hepatic encephalopathy. Treatment involves supportive care and managing complications such as cerebral edema. Prognosis is assessed using scoring systems like King's College criteria, with liver transplantation indicated for those who do not recover spontaneously.
The Medical Assessment and Management of OliguriaLuis Daniel Lugo
The document discusses the medical assessment and management of oliguria. It defines oliguria as urine output less than 400 mL per day in adults. Oliguria can result from prerenal, intrinsic renal, or postrenal causes. The assessment of oliguria involves urine analysis and blood tests to evaluate electrolytes, BUN, creatinine, and acid-base balance. Medical management focuses on treating the underlying cause, managing fluid balance and hyperkalemia, and considering dialysis for complications like volume overload or refractory acidosis. Identifying and treating reversible causes is important for prognosis, which depends on etiology and comorbidities.
This document discusses acute kidney injury (AKI), providing definitions, causes, evaluation, and treatment. It notes that AKI is a sudden reduction in kidney function that can be caused by pre-renal issues like low blood volume, renal issues affecting the kidneys directly, or post-renal obstruction. Common causes include sepsis, hypotension, nephrotoxins, and acute tubular necrosis. Evaluation involves history, exam, labs including electrolytes and urine analysis, and sometimes renal ultrasound or biopsy. Treatment depends on the underlying cause but generally involves fluid resuscitation, removing nephrotoxins, treating infections, and potentially renal replacement therapy. Prognosis depends on factors like age, illness duration, organ
This document provides an overview of pharmacotherapy for renal disorders. It begins by outlining various renal disorders including acute renal failure, chronic renal failure, drug-induced renal disease, glomerulonephritis, nephrotic/nephritic syndromes, acid-base disorders, and disorders of fluid and electrolyte homeostasis. It then focuses on acute kidney injury (AKI), discussing definition, staging, risk factors, pathophysiology, clinical presentation, investigations, and management. Prevention and treatment of specific causes of AKI like contrast-induced nephropathy and nephrolithiasis are also covered.
Chris, a diabetic patient, began experiencing decreased urine output and increased lethargy. His doctor diagnosed him with acute kidney injury secondary to his uncontrolled diabetes. Acute kidney injury is a sudden decrease in kidney function that can be caused by factors like decreased blood flow, nephrotoxic drugs, or urinary obstruction. Chris's symptoms and elevated creatinine and potassium levels on lab tests confirmed the diagnosis.
Acute renal failure in children is defined as a sudden deterioration in renal function resulting in the inability to maintain fluid and electrolyte homeostasis. It can be classified as pre-renal, intrinsic renal, or post-renal. Common causes include dehydration, infections, nephrotoxins, and obstructions. Symptoms include decreased urine output, edema, and mental changes. Treatment involves fluid resuscitation, electrolyte management, dialysis for complications like hyperkalemia, and treating the underlying cause. The prognosis depends on the cause, with acute tubular necrosis having a 90% complete remission rate.
Acute Kidney Injury (AKI) is a common complication, affecting 5-7% of hospital admissions and 30% of intensive care unit patients. The top causes of AKI in India are diarrheal diseases, sepsis, malaria, drug toxicity, and hospital-acquired injuries. Biomarkers like cystatin C and kidney injury molecule 1 can help detect AKI earlier than creatinine. Treatment involves fluid resuscitation, eliminating nephrotoxins, and renal replacement therapy for complications like electrolyte imbalances or uremia. Outcomes depend on the underlying cause, with pre-renal and post-renal AKI having a better prognosis than intrinsic renal injury.
This document provides guidance on evaluating and differentiating between causes of acute kidney injury (AKI). It discusses the clinical evaluation of patients with AKI including assessing urgency, determining if the dysfunction is acute or chronic, and identifying potential causes. Diagnostic tests are outlined including lab values, imaging, and biomarkers to help determine if the AKI is prerenal, renal, or post-renal. Emerging urine and blood biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) that can rapidly and reliably detect early kidney injury are also summarized.
The document discusses common renal pathologies and their management in the perioperative period. It covers acute renal failure (ARF), chronic renal failure (CRF), diabetic nephropathy, nephrotic syndrome, glomerulonephritis, and pyelonephritis. ARF is classified as prerenal, intrinsic, or postrenal based on etiology. CRF results in fluid and electrolyte abnormalities, cardiac and pulmonary issues, and anemia. Diabetic nephropathy is caused by hypertension and hyperglycemia damaging the kidneys over time. Treatment focuses on controlling blood sugar and hypertension.
This document discusses acute kidney injury (AKI), including its definition, causes, diagnostic approach, and management. It describes renal autoregulation and how various vasoconstrictors and vasodilators maintain renal blood flow. Prerenal, intrinsic, and postrenal causes of AKI are outlined. The diagnostic approach involves assessing history, physical exam, labs, and imaging to determine the etiology. Urine sediment analysis can provide clues about the underlying renal process. Management involves treating the underlying cause and preventing further injury.
This document provides an overview of acute kidney injury (AKI), formerly known as acute renal failure. It discusses the definition and epidemiology of AKI and describes the main causes as pre-renal, intrinsic renal, and post-renal. Pre-renal AKI is the most common type and is caused by reduced renal blood flow. The document outlines the diagnostic evaluation, complications, treatment approaches including dialysis indications, and outcomes of AKI. It emphasizes the importance of identifying and eliminating nephrotoxic agents to optimize management of this condition.
This document discusses acute kidney injury (AKI), formerly known as acute renal failure. It provides definitions of AKI, outlines criteria for diagnosis including RIFLE and AKIN classifications, and discusses etiologies such as pre-renal causes, acute tubular necrosis, interstitial nephritis, and glomerulonephritis. Risk factors, presentations, evaluations, and biomarkers for AKI are presented. Prevention and management of AKI in hepatic dysfunction and hepatorenal syndrome are also covered.
Acute renal failure (ARF) is defined as a rapid decline in kidney function over days or weeks. It can be caused by pre-renal factors that decrease blood flow to the kidneys, intrinsic renal disease, or post-renal obstruction of urine flow. ARF is characterized by rising levels of blood urea and creatinine, decreased urine output, and a decline in glomerular filtration rate. Diagnosis involves laboratory tests of blood and urine as well as imaging studies like ultrasound. Complications of ARF include electrolyte imbalances, pulmonary edema, bleeding, and metabolic acidosis. Prevention focuses on avoiding dehydration in high-risk patients and using caution with nephrotoxic drugs.
This document provides an overview of acute kidney injury (AKI). It discusses the definition and incidence of AKI, noting that it occurs in 5% of hospitalized patients and 30% of ICU admissions. It then covers the concept and considerations of AKI, including that serum creatinine is a late indicator and early diagnosis enables timely treatment. It describes the classification of AKI as pre-renal, intrinsic renal, or post-renal and covers causes such as sepsis, nephrotoxins, tubular obstruction, and glomerular or vascular disease. Complications of AKI including hyperkalemia and metabolic acidosis are also summarized.
The document discusses acute renal failure (ARF), which refers to a sudden and usually reversible loss of renal function that develops over days or weeks. ARF can be pre-renal, intrinsic renal, or post-renal in cause. Reversible pre-renal ARF occurs when haemodynamic disturbances like hypotension produce acute dysfunction that can be rapidly reversed by treating the underlying cause and restoring renal perfusion. Left untreated, pre-renal ARF can progress to established acute tubular necrosis. Proper diagnosis involves assessing the cause, signs of poor perfusion, and urine and blood tests. Management focuses on correcting the underlying problem and restoring blood volume through fluids.
This document discusses acute kidney injury (AKI), formerly known as acute renal failure. It defines AKI as the rapid deterioration of renal function over hours to days, resulting in the failure of the kidneys to excrete waste and regulate fluids and electrolytes. AKI can be classified in different ways, including whether urine output is low or normal. Prerenal, renal, and postrenal causes of AKI are described. The epidemiology, etiology, diagnosis, and management of AKI are also outlined. Treatment involves supportive care through fluid management, electrolyte correction, and potentially renal replacement therapy in severe cases.
This case involves a 7-year-old female presenting with acute renal failure, facial swelling, and hematuria. She had been treated for malaria and pneumonia in the past month. Her creatinine was elevated at 1711 umol/L, indicating severe acute renal injury. Possible causes of her acute renal failure include an allergic reaction to antibiotics like gentamicin or cephalosporins, or nephrotoxicity from multiple antibiotic exposures over the past month. Her renal failure should be managed by discontinuing any nephrotoxic medications, aggressive hydration, and monitoring of her renal function.
This document provides an overview of acute liver failure (ALF), including its definition, classification, etiology, clinical manifestations, diagnosis, treatment, complications, prognosis, and liver support devices. ALF is defined as evidence of coagulation abnormalities and mental alterations in a patient without preexisting cirrhosis within 26 weeks of illness onset. Common etiologies in India include hepatitis E, drug-induced liver injury, and acetaminophen toxicity. Presentation may include jaundice, coagulopathy, and hepatic encephalopathy. Treatment involves supportive care and managing complications such as cerebral edema. Prognosis is assessed using scoring systems like King's College criteria, with liver transplantation indicated for those who do not recover spontaneously.
The Medical Assessment and Management of OliguriaLuis Daniel Lugo
The document discusses the medical assessment and management of oliguria. It defines oliguria as urine output less than 400 mL per day in adults. Oliguria can result from prerenal, intrinsic renal, or postrenal causes. The assessment of oliguria involves urine analysis and blood tests to evaluate electrolytes, BUN, creatinine, and acid-base balance. Medical management focuses on treating the underlying cause, managing fluid balance and hyperkalemia, and considering dialysis for complications like volume overload or refractory acidosis. Identifying and treating reversible causes is important for prognosis, which depends on etiology and comorbidities.
This document discusses acute kidney injury (AKI), providing definitions, causes, evaluation, and treatment. It notes that AKI is a sudden reduction in kidney function that can be caused by pre-renal issues like low blood volume, renal issues affecting the kidneys directly, or post-renal obstruction. Common causes include sepsis, hypotension, nephrotoxins, and acute tubular necrosis. Evaluation involves history, exam, labs including electrolytes and urine analysis, and sometimes renal ultrasound or biopsy. Treatment depends on the underlying cause but generally involves fluid resuscitation, removing nephrotoxins, treating infections, and potentially renal replacement therapy. Prognosis depends on factors like age, illness duration, organ
This document provides an overview of pharmacotherapy for renal disorders. It begins by outlining various renal disorders including acute renal failure, chronic renal failure, drug-induced renal disease, glomerulonephritis, nephrotic/nephritic syndromes, acid-base disorders, and disorders of fluid and electrolyte homeostasis. It then focuses on acute kidney injury (AKI), discussing definition, staging, risk factors, pathophysiology, clinical presentation, investigations, and management. Prevention and treatment of specific causes of AKI like contrast-induced nephropathy and nephrolithiasis are also covered.
Chris, a diabetic patient, began experiencing decreased urine output and increased lethargy. His doctor diagnosed him with acute kidney injury secondary to his uncontrolled diabetes. Acute kidney injury is a sudden decrease in kidney function that can be caused by factors like decreased blood flow, nephrotoxic drugs, or urinary obstruction. Chris's symptoms and elevated creatinine and potassium levels on lab tests confirmed the diagnosis.
Acute renal failure in children is defined as a sudden deterioration in renal function resulting in the inability to maintain fluid and electrolyte homeostasis. It can be classified as pre-renal, intrinsic renal, or post-renal. Common causes include dehydration, infections, nephrotoxins, and obstructions. Symptoms include decreased urine output, edema, and mental changes. Treatment involves fluid resuscitation, electrolyte management, dialysis for complications like hyperkalemia, and treating the underlying cause. The prognosis depends on the cause, with acute tubular necrosis having a 90% complete remission rate.
Acute Kidney Injury (AKI) is a common complication, affecting 5-7% of hospital admissions and 30% of intensive care unit patients. The top causes of AKI in India are diarrheal diseases, sepsis, malaria, drug toxicity, and hospital-acquired injuries. Biomarkers like cystatin C and kidney injury molecule 1 can help detect AKI earlier than creatinine. Treatment involves fluid resuscitation, eliminating nephrotoxins, and renal replacement therapy for complications like electrolyte imbalances or uremia. Outcomes depend on the underlying cause, with pre-renal and post-renal AKI having a better prognosis than intrinsic renal injury.
This document provides guidance on evaluating and differentiating between causes of acute kidney injury (AKI). It discusses the clinical evaluation of patients with AKI including assessing urgency, determining if the dysfunction is acute or chronic, and identifying potential causes. Diagnostic tests are outlined including lab values, imaging, and biomarkers to help determine if the AKI is prerenal, renal, or post-renal. Emerging urine and blood biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) that can rapidly and reliably detect early kidney injury are also summarized.
The document discusses common renal pathologies and their management in the perioperative period. It covers acute renal failure (ARF), chronic renal failure (CRF), diabetic nephropathy, nephrotic syndrome, glomerulonephritis, and pyelonephritis. ARF is classified as prerenal, intrinsic, or postrenal based on etiology. CRF results in fluid and electrolyte abnormalities, cardiac and pulmonary issues, and anemia. Diabetic nephropathy is caused by hypertension and hyperglycemia damaging the kidneys over time. Treatment focuses on controlling blood sugar and hypertension.
This document discusses acute kidney injury (AKI), including its definition, causes, diagnostic approach, and management. It describes renal autoregulation and how various vasoconstrictors and vasodilators maintain renal blood flow. Prerenal, intrinsic, and postrenal causes of AKI are outlined. The diagnostic approach involves assessing history, physical exam, labs, and imaging to determine the etiology. Urine sediment analysis can provide clues about the underlying renal process. Management involves treating the underlying cause and preventing further injury.
This document provides an overview of acute kidney injury (AKI), formerly known as acute renal failure. It discusses the definition and epidemiology of AKI and describes the main causes as pre-renal, intrinsic renal, and post-renal. Pre-renal AKI is the most common type and is caused by reduced renal blood flow. The document outlines the diagnostic evaluation, complications, treatment approaches including dialysis indications, and outcomes of AKI. It emphasizes the importance of identifying and eliminating nephrotoxic agents to optimize management of this condition.
This document discusses acute kidney injury (AKI), formerly known as acute renal failure. It provides definitions of AKI, outlines criteria for diagnosis including RIFLE and AKIN classifications, and discusses etiologies such as pre-renal causes, acute tubular necrosis, interstitial nephritis, and glomerulonephritis. Risk factors, presentations, evaluations, and biomarkers for AKI are presented. Prevention and management of AKI in hepatic dysfunction and hepatorenal syndrome are also covered.
Acute renal failure (ARF) is defined as a rapid decline in kidney function over days or weeks. It can be caused by pre-renal factors that decrease blood flow to the kidneys, intrinsic renal disease, or post-renal obstruction of urine flow. ARF is characterized by rising levels of blood urea and creatinine, decreased urine output, and a decline in glomerular filtration rate. Diagnosis involves laboratory tests of blood and urine as well as imaging studies like ultrasound. Complications of ARF include electrolyte imbalances, pulmonary edema, bleeding, and metabolic acidosis. Prevention focuses on avoiding dehydration in high-risk patients and using caution with nephrotoxic drugs.
This document provides an overview of acute kidney injury (AKI). It discusses the definition and incidence of AKI, noting that it occurs in 5% of hospitalized patients and 30% of ICU admissions. It then covers the concept and considerations of AKI, including that serum creatinine is a late indicator and early diagnosis enables timely treatment. It describes the classification of AKI as pre-renal, intrinsic renal, or post-renal and covers causes such as sepsis, nephrotoxins, tubular obstruction, and glomerular or vascular disease. Complications of AKI including hyperkalemia and metabolic acidosis are also summarized.
The document discusses acute renal failure (ARF), which refers to a sudden and usually reversible loss of renal function that develops over days or weeks. ARF can be pre-renal, intrinsic renal, or post-renal in cause. Reversible pre-renal ARF occurs when haemodynamic disturbances like hypotension produce acute dysfunction that can be rapidly reversed by treating the underlying cause and restoring renal perfusion. Left untreated, pre-renal ARF can progress to established acute tubular necrosis. Proper diagnosis involves assessing the cause, signs of poor perfusion, and urine and blood tests. Management focuses on correcting the underlying problem and restoring blood volume through fluids.
This document discusses acute kidney injury (AKI), formerly known as acute renal failure. It defines AKI as the rapid deterioration of renal function over hours to days, resulting in the failure of the kidneys to excrete waste and regulate fluids and electrolytes. AKI can be classified in different ways, including whether urine output is low or normal. Prerenal, renal, and postrenal causes of AKI are described. The epidemiology, etiology, diagnosis, and management of AKI are also outlined. Treatment involves supportive care through fluid management, electrolyte correction, and potentially renal replacement therapy in severe cases.
This case involves a 7-year-old female presenting with acute renal failure, facial swelling, and hematuria. She had been treated for malaria and pneumonia in the past month. Her creatinine was elevated at 1711 umol/L, indicating severe acute renal injury. Possible causes of her acute renal failure include an allergic reaction to antibiotics like gentamicin or cephalosporins, or nephrotoxicity from multiple antibiotic exposures over the past month. Her renal failure should be managed by discontinuing any nephrotoxic medications, aggressive hydration, and monitoring of her renal function.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
2. • Most common intrinsic cause of acute kidney injury
• Renal tubular cell damage and death
• Term ‘tubular necrosis’ is a misnomer, as true cellular necrosis is
usually minimal
• Acute tubular necrosis is precipitated by an acute ischemic or toxic
event or sepsis.
3.
4.
5. Ischemic-Induced Acute Tubular Necrosis:
-Any factor that leads to prerenal azotemia can lead to ischemic acute
tubular necrosis.
-Hypovolemic states such as diarrhoea, vomiting, bleeding, dehydration,
burns, renal losses via diuretics or osmotic diuresis, and third space
sequestration.
6. Ischemic-Induced Acute Tubular Necrosis:
-Oedematous states such as heart failure and cirrhosis cause reduced
kidney perfusion.
-Sepsis or anaphylaxis leads to systemic vasodilation.
-Coagulopathy, such as disseminated intravascular coagulation, can also
cause acute tubular necrosis.
7. Nephrotoxic-Induced Acute Tubular Necrosis:
• ENDOTOXINS MEDIATED:
--Heme pigment-containing proteins such as hemoglobin and myoglobin
--Crystal-induced nephropathy due to high cell turnover such as uric
acid, calcium phosphate crystals in the setting of ongoing malignancy
treatment
--Light chain accumulation in multiple myeloma
9. Sepsis-Induced Acute Tubular Necrosis
• Systemic hypotension and renal hypoperfusion.
• Inflammatory cytokines and reactive oxygen species
• Bacterial toxins
10. HISTOLOGY
• Typical features of ATN include vacuolization and loss of brush border
in proximal tubular cells.
• Sloughing of tubular cells into the lumen leads to cast obstruction,
manifested by tubular dilation.
11.
12. EVALUATION
• The workup is usually to differentiate acute tubular necrosis from
prerenal AKI and other causes of AKI
13.
14. Ratio of Blood Urea Nitrogen to Creatinine
• In prerenal AKI the ratio may exceed 20:1 because of a disproportionate
increase in urea reabsorption resulting from elevated serum vasopressin
levels.
• Upper gastrointestinal tract bleeding, impaired protein anabolism (e.g.,
systemic corticosteroid administration), increased catabolism (e.g., sepsis),
and increased protein intake all raise BUN levels.
• Furthermore, diminished urea production from decreased protein intake
or underlying liver disease are associated with lower BUN levels.
15. Fractional Excretion of Sodium and Urea
• FENa = [U/S] Na / [U/S] Cr × 100%
• Basic premise is that renal tubular cells will reabsorb sodium in the
prerenal setting, whereas tubules damaged by ATN will not.
• FENa less than 1% is consistent with prerenal AKI, and FENa greater
than 3% is typical of ATN
16. • However, FENa may be less than 1% despite ATN in the setting of
sepsis, hemoglobinuria or myoglobinuria, radiocontrast exposure,
heart failure, and advanced cirrhosis
• Underlying CKD, diuretic use, recent intravenous fluid administration,
glycosuria, bicarbonaturia, and salt wasting disorders may be
associated with elevated FENa despite the presence of prerenal AKI
17. • Urea reabsorption, primarily occurring in proximal tubules, is less
affected by loop and thiazide diuretics, and the fractional excretion of
urea (FEUrea) may be an alternative to FENa in patients receiving
diuretics.
• The calculation of FEUrea is identical to that of FENa, and values less
than 35% favor prerenal AKI over ATN.
18. • Urinalysis (UA)
--In prerenal disease, the UA microscopy is normal or may contain hyaline
casts.
--UA of acute tubular necrosis - muddy brown casts
• Urine sodium concentration:
• This test determines whether kidney is trying to conserve sodium or lose
sodium due to tubular injury with values more than 40 to 50 mEq/L
indicating acute tubular necrosis and less than 20 mEq/L suggestive of
prerenal disease
19. URINE – MUDDY BROWN GRANULAR CASTS
• In hospitalized patients with AKI, the presence of more than 10
granular casts per low-power field had a positive predictive value of
100% for a final diagnosis of ATN
20. Kidney Biopsy
• Kidney biopsy is reserved for patients in whom prerenal and postrenal
AKI have been excluded and the cause of intrinsic AKI remains unclear
• Particularly useful when clinical assessment and laboratory
investigations suggest diagnoses other than ischemic or nephrotoxic
injury that may respond to disease specific therapy (e.g., vasculitis,
systemic lupus erythematosus, and AIN).
21. MANAGEMENT
• 1) Treatment of the underlying cause
• 2) Maintain Fluid balance/avoid pre-renal insult
• 3) Diuretics not indicated to convert oliguric AKI to non-oliguric
AKI(only indicated for fluid overload – may need RRT)
• 4) Avoid and stop all nephrotoxic drugs
22. • Indications for urgent dialysis in patients with ATN include the
following:
• Refractory fluid overload
• Severe hyperkalemia
• Signs of uremia (eg, pericarditis, encephalopathy, altered
mental status)
• Severe metabolic acidosis (pH < 7.1)
23. • In patients without an indication for dialysis, initiating renal
replacement therapy (RRT) prophylactically offers no benefit
over performing RRT as and when required. Several trials and
meta-analysis have shown no improvement in outcome with
early versus late RRT for patients with AKI
24. COMPLICATIONS OF ATN
• Volume overload
• Acid-base and electrolyte imbalances, especially Hyperkalemia,
acidosis, hyperphosphatemia, and hypocalcemia
• Uremia, leading to problems such as prolonged bleeding,
altered mental status, and pericardial disease
26. Neutrophil Gelatinase-Associated Lipocalin(NGAL)
• Widely expressed in a variety of adult human tissues, including prostate,
salivary gland, stomach, colon, trachea, lung, liver and kidney
• Major renal source of urinary NGAL is from the thick ascending limb and
collecting ducts.
• Non-specific plasma NGAL can be filtered through glomeruli and be absorbed
in the proximal tubules
27. • Thus, urine NGAL elevation could reflect the decreased absorption of filtered
NGAL due to dysfunction or injury in the proximal tubules and/or increased
NGAL release from the thick ascending limb and collecting ducts
• Dramatically upregulated following ischemic or nephrotoxic kidney injury.
• As early as 3h following the injury, elevated NGAL protein is detectable in the
urine
28. Liver-Type Fatty Acid-Binding Protein(L-FABP)
• Expressed in the proximal tubules.
• Urinary L-FABP levels increase almost immediately and peak within 6 h after
tubular injury
• Exact function of L-FABP is yet to be fully elucidated. It is however considered
a renal protective protein in general.
• It binds to and promotes the metabolism of fatty acids and possesses
antioxidant properties
29. Interleukin-18
• Pro-inflammatory cytokine formed in the proximal tubular cells.
• Urinary IL-18 is elevated following renal injury
• AKI patients with high urine IL-18 concentration could potentially benefit from
anti-IL-18 therapy, although its utility is yet to be validated
30. Urinary Insulin-Like Growth Factor-Binding Protein 7 and Tissue
Inhibitor of Metalloproteinase-2
• TIMP-2 and IGFBP-7 are inducers of G1 cell cycle arrest of renal tubular cells,
which occurs during the early period of cell injury caused by ischemic or
inflammatory processes
• Failure to achieve G1 cell cycle arrest can lead to an increased proportion of
renal tubular cells in the G2/M phase, which in the animal model shows to be
correlated with lasting kidney damage, including extensive glomerulosclerosis
and interstitial fibrosis
31. Serum and Urine Kidney Injury Molecule 1
• Very low expression in the normal kidney. Its expression is markedly
upregulated after ischemia-reperfusion injury.
• Reflects the proliferating dedifferentiated epithelial cells of the proximal
tubules and appears to peak at approximately 48 h
• Promotes epithelial regeneration and regulates tubule cell apoptosis.
32. • Persistent KIM-1 elevation in blood, however, indicates ongoing tubular injury,
which would be a risk for the development of CKD/ESRD.
• Urinary KIM-1 shows similar correlation of kidney injury
33. CLINICAL CASE – 1 (SEPSIS INDUCED ATN)
• Mrs. Johnson is brought to the emergency department by ambulance with a one-day
history of high fever, confusion, and decreased urine output. She has a known diabetic
foot ulcer for which she has been receiving outpatient wound care.
• Initial Assessment:
• Vital Signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 24
breaths/min, temperature 39.5°C.
• Physical Examination: Mrs. Johnson appears acutely ill and disoriented. She has cool
extremities with weak peripheral pulses. Lung examination reveals bilateral crackles. Her
foot ulcer shows signs of cellulitis with surrounding erythema and tenderness.
• Laboratory Investigations:
• Serum Creatinine: 4.0 mg/dL (baseline 1.0 mg/dL)
• Blood Urea Nitrogen (BUN): 50 mg/dL
• Serum Potassium: 5.6 mmol/L
• White Blood Cell Count: 20,000/mm³ with left shift
• Arterial Blood Gas (ABG): pH 7.32, pCO2 30 mmHg, HCO3- 18 mmol/L
• Urinalysis: Proteinuria (3+), muddy brown granular casts, few red blood cells, few white blood cells.
34. CLINICAL CASE – 2(NEPHROTOXIC INDUCED
ATN)
• Mr. Lee presents to the emergency department with complaints of nausea,
vomiting, and decreased urine output for the past two days. He reports recent
use of over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) for
worsening knee pain.
• Initial Assessment:
• Vital Signs: Blood pressure 140/90 mmHg, heart rate 80 bpm, respiratory rate
16 breaths/min, temperature 37.0°C.
• Physical Examination: Mr. Lee appears dehydrated and mildly lethargic. His
abdomen is soft and non-tender with no rebound tenderness. Lung and heart
examinations are unremarkable.
• Laboratory Investigations:
• Serum Creatinine: 3.5 mg/dL (baseline 1.0 mg/dL)
• Blood Urea Nitrogen (BUN): 45 mg/dL
• Serum Potassium: 5.2 mmol/L
• Urinalysis: Proteinuria (1+), muddy brown granular casts, few red blood cells, few white
blood cells.
35. CLINICAL CASE – 3(ISCHEMIA INDUCED ATN)
• Mr. Johnson is brought to the emergency department by ambulance following a motor
vehicle accident. He was found unconscious at the scene and is now awake but
confused. He complains of severe abdominal pain and has not passed urine since the
accident.
• Initial Assessment:
• Vital Signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 22
breaths/min, temperature 37.2°C.
• Physical Examination: Mr. Johnson appears lethargic and in distress. His abdomen is
tender on palpation, with guarding and rebound tenderness in the bilateral flanks. There
are no other significant findings on cardiovascular or respiratory examination.
• Laboratory Investigations:
• Serum Creatinine: 6.0 mg/dL (baseline unknown)
• Blood Urea Nitrogen (BUN): 70 mg/dL
• Serum Potassium: 6.2 mmol/L
• Arterial Blood Gas (ABG): pH 7.28, pCO2 30 mmHg, HCO3- 18 mmol/L
• Urinalysis: Proteinuria (3+), muddy brown granular casts, few red blood cells, few white blood cells.